Latest News

HHS on a phone | Image credit: Timon - stock.adobe.com
HHS Praises Biosimilars Savings but Opportunities to Reduce Part B Spending Remain

November 28th 2023

Although biosimilars have already generated savings for Medicare Part B programs and beneficiaries, opportunities for substantial reductions in spending remain, according to a report from the HHS.

Image credit: Aliaksandr Marko | stock.adobe.com
Confusion Persists Around the Interchangeability Designation for Biosimilars

November 23rd 2023

injectable pens
BioRationality: FDA Publishes Results of First Meta-Analysis to Conclude All Biosimilars Are Interchangeable

November 20th 2023

Eye on Pharma banner
Eye on Pharma: Denosumab Biosimilar Data; COA Forms New Committee; IGBA and WHO Collaborate

November 8th 2023

drug in a vial | Image credit: Prasanth - stock.adobe.com
BioRationality: FDA Launches a New Opportunity to Remove Redundant Trials of Biosimilars

November 6th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.